계명대학교 의학도서관 Repository

The Association between Urine Albumin to Creatinine Ratio and Osteoporosis in Postmenopausal Women with Type 2 Diabetes

Metadata Downloads
Affiliated Author(s)
조호찬
Alternative Author(s)
Cho, Ho Chan
Journal Title
Journal of Bone Metabolism
ISSN
2287-6375
Issued Date
2016
Keyword
AlbuminsCreatinineDiabetes mellitus type 2Osteoporosis postmenopausal
Abstract
Background: Osteoporosis is a progressive bone disease that is characterized by a decrease in bone mass density and destruction of microstructure, which can lead to an increased risk of fracture. Although many studies have been published about the relationship between end-stage renal disease and osteoporosis, research on the relationship between proteinuria and the prevalence of osteoporosis is still lacking. Methods: We assessed 91 postmenopausal women with type 2 diabetes who visited our hospital from January 2009 to January 2012. Results: Among 91 patients, the prevalence of osteoporosis and osteopenia was 35.2% (32 cases) and 32.9% (30 cases) according to bone mineral density. The patients with microalbuminuria and macroalbuminuria (urine albumin-to-creatinine ratio [UACR] ≥ 30) had a significantly higher incidence of osteoporosis compared to subjects with normoalbuminuria (P<0.05). Conclusions: This study indicates that UACR may be a useful biomarker for increased risk of osteoporosis in postmenopausal women with type 2 diabetes who have been linked to higher UACR levels.
Department
Dept. of Internal Medicine (내과학)
Publisher
School of Medicine
Citation
Ye Yeon Lee et al. (2016). The Association between Urine Albumin to Creatinine Ratio and Osteoporosis in Postmenopausal Women with Type 2 Diabetes. Journal of Bone Metabolism, 23(1), 1–7. doi: 10.11005/jbm.2016.23.1.1
Type
Article
ISSN
2287-6375
DOI
10.11005/jbm.2016.23.1.1
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/33304
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.